DutyPills.com

Beta-lactamase inhibitor

Clavulanate with liver impairment: dosing and safety

The liver is the main site of metabolism for many medications including Clavulanate (Clavulanate). Liver impairment slows clearance and can raise plasma levels of Clavulanate above the intended range, amplifying side effects. People with chronic liver disease, recent hepatitis or significantly raised liver enzymes need a tailored approach to Clavulanate at 500/125mg, 875/125mg, 1000/62.5mg.

Why liver function matters

Clavulanate undergoes hepatic metabolism through CYP enzymes for many medications. Reduced hepatic function slows this metabolism, prolongs the half-life and raises plasma concentrations. Clavulanate binds irreversibly to the active site of many class A beta-lactamases produced by bacteria, acting as a 'suicide inhibitor'. The prescribing information typically classifies severity by Child-Pugh score (A mild, B moderate, C severe) and gives dose adjustments accordingly.

Practical guidance

According to the prescribing information for Clavulanate, baseline liver function tests are recommended before starting Clavulanate in any patient with risk factors and periodically during treatment in chronic liver disease. Severe impairment (Child-Pugh C) often contraindicates Clavulanate or requires substantial dose reduction; mild impairment usually permits standard 500/125mg, 875/125mg, 1000/62.5mg with closer monitoring.

Frequently asked questions

Is Clavulanate safe with liver problems?

Mild liver impairment typically allows Clavulanate at standard or slightly reduced 500/125mg, 875/125mg, 1000/62.5mg with monitoring. Moderate-to-severe impairment often requires substantial dose reduction. Severe (Child-Pugh C) impairment may contraindicate Clavulanate entirely.

Will Clavulanate damage my liver?

Most Beta-lactamase inhibitor medications at standard 500/125mg, 875/125mg, 1000/62.5mg doses do not harm a healthy liver. A small subset can produce drug-induced liver injury in susceptible patients, usually detected by routine ALT/AST monitoring. The prescribing information for Clavulanate lists the documented risk.

Products containing Clavulanate

More on Clavulanate

The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.